Pluri Inc.
+1.5% · 90d
$3.37
+0.02 (+0.75%)
News
(1)April 2026
Pluri Inc. (PLUR) Shareholders to Vote on Directors and Auditor
PLURPluri Inc.
# 📄 What This Document Is This is a **Definitive Proxy Statement (DEF 14A)** for **Pluri Inc. (PLUR)**. Think of it as the official "meeting agenda and information packet" sent to shareholders before an annual meeting. It tells you what will be voted on, who is running the company, how the bosses a
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%